Jayagopal Ashwath
Chief Scientific & Dev. Ofc.
Jayagopal Ashwath has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Apr 27, 2026.
On the most recent filing, Jayagopal Ashwath is listed as Chief Scientific & Dev. Ofc. at Opus Genetics, Inc. Inside the rolling window, Jayagopal Ashwath reported no open-market purchases and 2 open-market sales totaling $58K in IRD. The largest disclosed transaction in the window is a sale of 7,542 IRD shares on Apr 23, 2026, worth $39K.
Companies traded
Other insiders at IRD
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$58K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Jayagopal Ashwath made?
Jayagopal Ashwath has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company since 2026.
Which companies does Jayagopal Ashwath trade?
Jayagopal Ashwath has filed SEC Form 4 disclosures for 1 company, including IRD.
When was Jayagopal Ashwath's most recent SEC Form 4 filing?
Jayagopal Ashwath's most recent SEC Form 4 filing on Tracefour is dated Apr 27, 2026.
What is Jayagopal Ashwath's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Jayagopal Ashwath is listed as Chief Scientific & Dev. Ofc..
What is Jayagopal Ashwath's total buy and sell value in the current window?
Inside the rolling retention window, Jayagopal Ashwath bought $0 and sold $58K based on SEC Form 4 filings.
What was Jayagopal Ashwath's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 7,542 IRD shares on 2026-04-23, worth $39K, per SEC Form 4 filings.